🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thuy Tran

Yale University

ORCID: 0000-0002-6244-7575

Also affiliated with Smilow Cancer Hospital

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 14 papers. Top paper: “Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial”.

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30111-x

N/A

6.6DataRank · unranked

541 citations

Kurt A. Schalper, Scott Gettinger, Amit Mahajan, Roy S. Herbst, Anne C. Chiang +19 more

On The Edge of Validation – Cancer Protease Fibroblast Activation Protein

Mini-Reviews in Medicinal Chemistry(2008)10.2174/138955708784567449

N/A

0.529DataRank · unranked

33 citations

Clifford Quan, Thuy Tran, Christian Wiesmann, Daniel Sutherlin, Beni Wolf

Targeting an essential viral oncoprotein with an IL-7-enhanced mRNA vaccine induces durable immunity to Merkel cell carcinoma

Cell Reports(2025)10.1016/j.celrep.2025.116359

N/A

0.104DataRank · unranked

1 citations

Kathryn Clulo, Yuewei Fei, Therese Cordero Dumit, Frankie Scallo, Jerry William Allen +12 more

Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma

Cellular and Molecular Life Sciences(2022)10.1007/s00018-022-04364-5

N/A

0DataRank · unranked

13 citations

Hongyi Zhang, Christopher R. Zito, Chetan K. Rane, Xianyong Ma, Olivia K. Provance +8 more

Coupled fibromodulin and SOX2 signaling as a critical regulator of distant metastasis initiation in melanoma

Research Square(2022)10.21203/rs.3.rs-1244262/v1

N/A

0DataRank · unranked

0 citations

Hongyi Zhang, Christopher R. Zito, Chetan K. Rane, Xianyong Ma, Thuy Tran +7 more

Lenvatinib or anti-VEGF in combination with anti–PD-1 differentially augments antitumor activity in melanoma

JCI Insight(2023)10.1172/jci.insight.157347

N/A

0DataRank · unranked

39 citations

Jasmine I. Caulfield, Lin Zhang, David A. Schoenfeld, Dijana Djureinovic, Veronica Chiang +6 more

The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma

JCI Insight(2023)10.1172/jci.insight.160024

N/A

0DataRank · unranked

6 citations

Matthew M. Grabowski, Balint Otvos, Defne Bayık, Wesley Wang, Ajay Zalavadia +25 more

CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cells

PLoS Biology(2024)10.1371/journal.pbio.3002905

N/A

0DataRank · unranked

33 citations

Keren David, Stav Rabani, Bar Lampert, Thuy Tran, Edward Doherty +9 more

MIF and CD74 as Emerging Biomarkers for Immune Checkpoint Blockade Therapy

Cancers(2024)10.3390/cancers16091773

N/A

0DataRank · unranked

28 citations

Rebecca A. Nichols, Thuy Tran, Arthur A. Vandenbark, Rajan P. Kulkarni, Rosalyn M. Fey

Patterns of brain metastases response to immunotherapy with pembrolizumab

Journal of Neuro-Oncology(2024)10.1007/s11060-024-04754-8

N/A

0DataRank · unranked

5 citations

Sarah Goldberg, Sarah A. Weiss, Thuy Tran, Kanwar Pal Singh, Kavita Joshi +4 more

Real-world outcomes with T-VEC in patients with anti-PD-1 resistant in-transit disease from melanoma and Merkel cell carcinoma

Surgical Oncology Insight(2024)10.1016/j.soi.2024.100120

N/A

0DataRank · unranked

1 citations

Madeline McNamara, Margaret A. Kaszycki, Alexander E. Frey, Jeffrey J. Ishizuka, Philippos Apolinário Costa +6 more

Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012358

N/A

0DataRank · unranked

4 citations

Noam Savion‐Gaiger, Ana Luisa Perdigoto, Jacqueline E. Mann, Madeline Candelas Torres, Genevieve M. Boland +12 more

Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells

Cancers(2021)10.3390/cancers13051049

N/A

0DataRank · unranked

14 citations

Chetan K. Rane, Christopher R. Zito, Sarah A. Weiss, Shlomit Jessel, Liliana E. Lucca +9 more

Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases

Journal of Neuro-Oncology(2020)10.1007/s11060-020-03619-0

N/A

0DataRank · unranked

27 citations

Christopher R. Zito, Thuy Tran, Kazuki Heishima, Veronique Neumeister, John J. McGuire +4 more